Login

Erik Kinnman, CEO, NeuroVive Pharmaceutical 00:00:00

Share On Facebook Share On Twitter

NeuroVive Pharmaceutical - Company presentation

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exploration Update on Red Lake and Western Australia Gold Projects
00:10:00
Inca One Gold Reports Near Record Q1 Performance
00:10:00
This week on Captains of Industry, we interview the leader of Africa's largest pharmaceutical manufacturer.
00:10:00
Platinum Group Metals CEO Discusses Palladium Project Development and Market Potential
00:10:00
Innovative Heart Health Diagnostics: An Interview with Chase Spoor of FluoroPharma
00:10:00
Shapiro Administration & CNX Resources Forge Environmental Monitoring Partnership | Nicholas J. DeIuliis- CEO of CNX Resources
00:10:00
Planet MicroCap's interview with Alice Chang, CEO of Perfect Corp. (NYSE: PERF), covers various topics including company insights and future plans.
00:10:00
Ion Energy Expands Exploration Efforts and Reports Positive Lithium Grades in Mongolia
00:10:00
In-Depth with Alex Kroes and Marijn Beuker: Collaboration, Vision, and the Future of Ajax | Alex Kroes, CEO, AFC Ajax N.V.
00:00:00
Neovasc uses conference to announce positive interim clinical data from Neovasc Reducer use - Bill Little, COO, Neovasc Inc
00:10:00
Bass Metals CEO Tim McManus Highlights Strong Financial Position and Growth Potential at Madagascar Graphite Project
00:10:00
Maha Energy is interviewed by Erik Penser Bank on May 23, 2022, discussing the company's performance and future outlook.

© 2026 Nehu